Document Page: First | Prev | Next | All | Image | This Release | Search
File: 120396_mar96_decls7_0017.txt
Subject: DAILY STAFF JOURNAL 12 NOV 90
Unit: XVIII CORPS
Parent Organization: ARCENT
Box ID: BX000036
Folder Title: DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90
Document Number: 2
Folder SEQ #: 34
UNCLASSIFIED
SIDE EFFECTS. ORDINARILY, DISCONTINUING PYRIDOSTIGMINE SHOULD BE
ADEQUATE TO ALLEVIATE SIGNS/SYMPTOMS. PYRIDOSTIGMINE MAY PERSIST IN
THE BLOOD FOR 24 HOURS, HOWEVER, AFTER BLOOD LEVELS PEAK IN 4 HOURS,
EFFECTS DIMINISH GRADUALLY. EMERGENCY TREATMENT INCLUDES
ADMINISTERING ATROPINE IN DOSES SUFFICIENT TO OVERCOME THE
CHOLINERGIC CRISIS. USE OF THE 2-MG ATROPINE SHOULD BE ADMINISTERED
BY MEDICAL PERSONNEL EVERY FIFTEEN-TWENTY (15-20) MINUTES. SEVERE
CASES MAY REQUIRE ASSISTED VENTILATION BUT WOULD BE UNUSUAL IF THE
EIGHT HOUR ADMINISTERED DOSE HAD BEEN FOLLOWED. WHEN STABILIZED,
THE CASUALITY MAY NEED EVACUATION FOR FURTHER OBSERVATION AND
TREATMENT.
PAGE 04 RUDCHAA0120
E. (U) USE OF PYRIDOSTIBMINE PRETREATMENT IN AIRCREW PERSONNEL
1. AT DIRECTION OF COGNIZANT COMMANDER, ALL PERSONNEL INCLUDING
DESIGNATED AIRCREW WILL TAKE PYRIDOSTISMINE AS OUTLINED INPREVIOUS
PARAS.
2. AIRCREW MAY FLY IMMEDIATELY.
3. FLIGHT SURGEONS WILL CLOSELY MONITOR ALL AIRCREWS TAKING
PYRIDOSTIGMINE INCLUDING, AS FAR AS POSSIBLE, DAILY CONTACT WITH EACH
CREW MEMBER.
4. FLIGHT SURGEONS AND AVIATION MEDICAL SAFETY OFFICERS SHOULD
BEGIN BRIEFING AIRCREWS ASAP CONCERNING USE AND POTENTIAL SIDE
EFFECTS OF PYRIDOSTIGMINE. EMPHASIS TO BE PLACED ON POTENTIAL
VISUAL IMPAIRMENT, PARTICULARLY AT NIGHT, AS WELL AS DECREASE IN HEAT
TOLERANCE.
5. PRETESTING AVIATION PERSONNEL IS NOT REQUIRED TO DETERMINE
ADVERSE EFFECTS.
F. (U) RESPONSIBILITIES. LOWEST LEVEL CHAIN OF COMMAND WILL
DECIDE TO BEGIN, CONTINUE OR DISCONTINUE THE NAPP PRETREATMENT
MEDICATION BASED ON THREAT. INTELLIGENCE OFFICERS AND MEDICAL
PERSONNEL ACT AS ADVISORS TO THE COMMANDER IN MAKING HIS DECISION
IF A CHEMICAL THREAT EXISTS. AFTER THREE DAYS OF USING NAPP
7-'AGE 05 RUDCHAA0120
COMMANDER AND STAFF SHOULD REEVALUATE COMBAT SITUATION TO DETERMINE
IF MEDICATION SHOULD BE CONTINUED OR DISCONTINUED. PRETREATMENT CAN
BEGIN AT ANY TIME DEPENDING ON THE SITUATION. IF PRETREATMENT IS
CONTINUED FOR SEVEN DAYS, AN ADDITIONAL NAPP MUST BE ISSUED AND
ADDITIONAL PACKS ORDERED. ADMINISTERING THE MEDICATION BEYOND
RECOMMENDED PERIOD OF 21 DAYS REQUIRES A THOROUGH EVALUATION OF
SITUATION.
5. (U) POTENTIAL RISK FOR ABUSE IS UNLIKELY. NAPP DOES NOT CREATE
A HIGH, EUPHORIC FEELING.
45. (U) NBC PI)C IS CPT WASDALT, COMM: 477-7777 EXT 3501, SURGEON
POC IS COL TSOULOS, ARCENT SURGEON, COMM: 477-7777 EXT 4075, TAC:
97664440.
DECL OARD
BT
#0120
UNCLASSIFIED
Document Page: First | Prev | Next | All | Image | This Release | Search
Document 17 f:/Week-10/BX000036/DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90/daily staff journal 12 nov 90:11089615153056
Control Fields 17
File Room = mar96_declassified
File Cabinet = Week-10
Box ID = BX000036
Unit = XVIII CORPS
Parent Organization = ARCENT
Folder Title = DUTY LOG G3 EOC INCOMING MSGS 12 NOV 90
Folder Seq # = 34
Subject = DAILY STAFF JOURNAL 12 NOV 90
Document Seq # = 2
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 08-NOV-1996